Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: AIM IN BRIEF: Herstal Emerges As Favourite To Acquire Manroy

Thu, 28th Nov 2013 12:27

(Correcting headline to refer to Herstal.)

LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Thursday:
--------
Mar City To Buy Eight Plots Of Land For About GBP30.8M; Launches GBP25.8M Placing
----------
NewRiver Retail To Buy 202 Pubs From Marston's For GBP90M; To Convert All Pubs To Other Uses; Buys Two Retail Centres For GBP34.3M; H1 Pretax Profit GBP5.2M Vs GBP479,000; Keeps Interim Dividend At 6.0P
----------
Idox Wins USD1.5M Contract With Unamed Canadian Oil & Gas Co.
----------
Plethora Solutions Says CEO Ronald Openshaw To Step Down; Says Non-Exec Director Mike Collis To Act As CFO; Says Intends To Further Strengthen Management Team
----------
Digital Barriers H1 Pretax Loss GBP7.2M Vs GBP7.1M Loss; Revenue GBP9M Vs GBP8.1M; Appoints New Finance Director
----------
Triple Plate Junction H1 Pretax Loss GBP234K Vs GBP320K; Spent GBP52,000 During The Period On Possible Transactions
----------
Brightside Appoints Paul Williams As New CEO From Early 2014
----------
Manroy Says Has Ended Takeover Talks With U.S. Ordnance But Still Talking With Herstal And Beretta; Says In "Active Discussions" With Herstal; Says Beretta Talks Not Active But Not Terminated
----------
Hummingbird Says Results Confirm Confidence On Tuzon Deposit; To Commence Additional Drilling At Site
----------
M&C Saatchi Agrees To Sell 75.1% Of Walker Media To Publicis Groupe For GBP36M In Cash; Will Retain 24.9% Of Walker Media And Have Right To Appoint Directors
----------
Leni Gas & Oil Says Plans To Drill First New Wells At Goudron Progress; Working With Authorities To Get Final Approvals
----------
Sigma Capital Agrees GBP700M Joint Venture With Gatehouse Bank For UK Privately Rented Residential Properties; JV To Build Initial 2,000 New Rental Homes In 22 Sites In North West Of England; JV Provides For Development Of 4,600 Additional New Rented Homes
----------
Publishing Technology: FY Results To Be Below Expectations Due To Delayed Completion Of Projects; Outlook For 2014 Remains A Steady Improvement
----------
Character Group FY Pretax Profit GBP0.72M Vs GBP7.1M; FY Sales GBP67.2M Vs GBP74.95M; Keeps Final Dividend At 3.30P; Says Saw A Turnaround In H2; Expects Substantially Better Results In 2014
----------
Ceramic Fuel Cells Sells 1,000 BlueGEN Units To Baltic Distributor For Over EUR20M
----------
Legendary Investments Says Virtualstock Limited Has Successfully Implemented Its System With Tesco
----------
Impax Asset Management FY Pretax profit GBP3.4M Vs GBP4.7M Loss; FY Revenue GBP18.5M Vs GBP18.6M
----------
Peninsular Gold FY Pretax Profit GBP2.3M Vs GBP3.0M; Rev From Unhedged Gold Sales GBP22.8M Vs GBP18.7M; Produced 5,836 Ounces Of Gold For Quarter July To Sept 2013
----------
Inland Home Signs Agreement With Defence Infrastructure Organisation For Wilton Park In Beaconsfield
----------
Pilat Media Q3 Profit After Tax GBP32,000 Vs GBP20,000 Loss; Revenue GBP6.29M Vs GBP5.31M; Says Strong Q4 To Results In Strong FY Revenue, Profit Growth
----------
ValiRx Says Has Received More Positive Studies On VAL201
----------
James Latham H1 Pretax Profit GBP4.2M Vs GBP4.1M; Rev GBP82.2M Vs GBP74.9M; Increases Interim Dividend To 3.4P Vs 3.1P
----------
Mercom Oil Sands Reaches Settlement With Nordic Petroleum On Chard Oil Sands Leases; Mercom Oil Sands To Pay Undisclosed Cash Sum, 13M New Shares
----------
Thor Mining Chairman: Challenges Ahead Are Securing Funds, Completing Upgrade To Molyhill Project; On Track To Increase Interest In Spring Hill To 80% By January 31 2014
----------
Mining Investments Resources FY Loss GBP368,000 Vs GBP634,000
----------
All Asia Asset Capital Buys Minority Stake In Myanmar Allure Group
--------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
31 Mar 2023 16:39

TRADING UPDATES: FireAngel signs with British Gas; Shanta pours gold

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
1 Mar 2023 20:09

TRADING UPDATES: Ediston signs 10-year lease with Marks & Spencer

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Mar 2023 14:26

ValiRx incorporates new wholly-owned lab subsidiary

(Sharecast News) - Life science company ValiRx announced the incorporation of a new wholly-owned subsidiary, Inaphaea BioLabs, on Wednesday.

Read more
3 Feb 2023 13:41

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
26 Jan 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 27 January 
Avon Protection PLCAGM
Henderson Far East Income LtdAGM
Ixico PLCAGM
NB Global Monthly Income Fund LtdEGM re proposed managed wind-down
On The Beach Group PLCAGM
Pathfinder Minerals PLCGM re capital raise
Serica Energy PLCGM re consideration shares approval
Treatt PLCAGM
Monday 30 January 
Bluebird Merchant Ventures LtdAGM
Contango Holdings PLCAGM
Hollywood Bowl Group PLCAGM
SkinBioTherapeutics PLCGM re annual report review
Starwood European Real Estate Finance LtdEGM re capital return 
Webis Holdings PLCAGM
Tuesday 31 January 
Hydrogen Future Industries PLCAGM
Mobile Streams PLCAGM
Residential Secure Income PLCAGM (TBC)
Star Phoenix Group LtdGM re removal and appointment of auditor
Team PLCAGM
Yamana Gold IncSGM re transaction with Agnico Eagle Mines Ltd and Pan American Silver Corp
Zamaz PLCAGM
Wednesday 1 February 
Baronsmead Second Venture Trust PLCAGM
Baronsmead Venture Trust PLCAGM
Capricorn Energy PLCGM re directors removal and appointment of new directors
Catalyst Media GroupAGM
Hyve Group PLCAGM
Imperial Brands PLCAGM
Premier Miton Group PLCAGM
Renew Holdings PLCAGM
Schroder Asia Pacific Fund PLCAGM
Thursday 2 February 
abrdn Equity Income Trust PLCAGM
Alteration Earth PLCAGM
Baillie Gifford European Growth Trust PLCAGM
JPMorgan Indian Investment Trust PLCAGM
Sage Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Tectonic Gold PLCAGM
ValiRx PLCGM re fundraising
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
17 Jan 2023 21:40

TRADING UPDATES: Future Metals in JV; Gunsynd sells stake in investee

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Jan 2023 13:31

IN BRIEF: ValiRx seeks up to GBP1.5 million for new research facility

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Raises GBP1 million from placing of 9.1 million shares at 11 pence each. Also will raise up to GBP500,000 more from a broker offer to retail investors at the same price. Turner Pope Investments Ltd will run the broker offer. Every four shares in the placing and retail offer come with a warrant to buy another new share at 14p over the next three years. Calls February 2 general meeting to approve the fund raise. Currently has a GBP10.1 million market capitalisation.

Read more
6 Dec 2022 11:31

ValiRx shares fall on test extension, but optimistic of other assets

(Alliance News) - ValiRx PLC on Tuesday saw shares drop, after extending its evaluation agreement with Hokkaido University to conduct further experimental testing.

Read more
24 Oct 2022 12:47

ValiRx forms new majority-owned breast cancer subsidiary

(Sharecast News) - Women's health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Monday, which had signed an intellectual property licence agreement with King's College London (KCL).

Read more
24 Oct 2022 10:05

ValiRx teams with King's College London for cancer project

(Alliance News) - ValiRx PLC on Monday said it is making progress on its goal to introduce new academic projects into its portfolio, after launching subsidiary company Cytolytix Ltd and signing a licence agreement with King's College London.

Read more
8 Sep 2022 11:47

IN BRIEF: ValiRx shares up on new interim chief scientific officer

ValiRx PLC - Nuneaton, England-based drug development company - Appoints Catherine Tralau-Stewart as interim chief scientific officer. Says she has experience working across leading pharmaceutical companies and academic groups. Tralau-Stewart will review new, incoming science; enhance the progress of existing projects; and influence the overall strategic scientific direction of the company, ValiRx adds. Chief Executive Suzy Dilly comments: "I'm looking forward to having another in-house scientist with whom to share ideas and to develop and deliver upon our strategic ambitions. Cathy's wealth of experience in exactly the areas in which we wish to progress, makes her an excellent choice for this role."

Read more
31 Aug 2022 13:51

EARNINGS UPDATES: Windward widens loss as operating expenses rise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Jul 2022 14:44

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is "good evidence" of biological activity and a "strong" rationale for further development. Adds that the drug candidate was investigated over nine months. Tests also demonstrate promising data on ovarian cancer cells, in addition to the targeted breast cancer cells. As a result, ValiRx has notified the academic team and intellectual property & licensing team at King's College London that it wants to proceed to full in-licensing.

Read more
5 Jul 2022 15:51

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option

ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expenses.

Read more
30 Jun 2022 17:31

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.